Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
104 studies found for:    dengue
Show Display Options
RSS Create an RSS feed from your search for:
dengue
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
81 Completed Implementation Research of New Dengue Vector Control Tools
Condition: DENGUE
Intervention: Other: Insecticide treated curtains and insecticide treated covers
82 Completed Celgosivir as a Treatment Against Dengue
Condition: Dengue Fever
Interventions: Drug: celgosivir;   Drug: placebo
83 Active, not recruiting Study of a Dengue Vaccine (V180) in Healthy Adults (V180-001)
Condition: Dengue
Interventions: Biological: Low-dose V180 with low-dose ISCOMATRIX™ adjuvant;   Biological: Low-dose V180 with medium-dose ISCOMATRIX™ adjuvant;   Biological: Medium-dose V180 (non-adjuvanted);   Biological: Medium-dose V180 with low-dose ISCOMATRIX™ adjuvant;   Biological: Medium-dose V180 with medium-dose ISCOMATRIX™ adjuvant;   Biological: Medium-dose V180 with Alhydrogel™ adjuvant;   Biological: High-dose V180 (non-adjuvanted);   Biological: High-dose V180 with low-dose ISCOMATRIX™ adjuvant;   Biological: High-dose V180 with medium-dose ISCOMATRIX™ adjuvant;   Biological: Low-dose V180 with high-dose ISCOMATRIX™ adjuvant;   Biological: Medium-dose V180 with high-dose ISCOMATRIX™ adjuvant;   Biological: High-dose V180 with high-dose ISCOMATRIX™ adjuvant;   Biological: Placebo
84 Not yet recruiting Efficacy and Safety of Ivermectin Against Dengue Infection
Condition: Dengue Fever
Interventions: Drug: 2 days Ivermectin;   Drug: 3 days Ivermectin;   Drug: Placebo
85 Completed A Study of Balapiravir in Patients With Dengue Virus Infection
Condition: Dengue
Interventions: Drug: balapiravir [RO4588161];   Drug: placebo
86 Completed Activated Recombinant Human Factor VII in Patients With Dengue Haemorrhagic Fever
Conditions: Acquired Bleeding Disorder;   Dengue Haemorrhagic Fever
Interventions: Drug: activated recombinant human factor VII;   Drug: placebo
87 Unknown  Clinical Evaluation of Insect Repellent and Insecticide Treated Nets in Lao PDR
Conditions: Malaria;   Dengue;   Japanese Encephalitis
Interventions: Drug: 20% deet insect repellent;   Drug: placebo control
88 Active, not recruiting Evaluating the Safety and Immune Response to Two Doses of a Dengue Virus Vaccine Administered 12 Months Apart
Condition: Dengue
Interventions: Biological: TV003 Vaccine;   Biological: Placebo Vaccine
89 Active, not recruiting A Comparison of the Safety and Immunogenicity of Various Schedules of Dengue Vaccine in Healthy Adult Volunteers
Condition: Healthy
Intervention: Biological: DENVax
90 Active, not recruiting Phase 1b Study Investigating Safety & Immunogenicity of DENVax Given Intradermally by Needle or Needle Free PharmaJet Injector
Condition: Normal Healthy Adult
Interventions: Biological: DENVax;   Device: PharmaJet Injector
91 Active, not recruiting Sensitivity Study of Diagnostic for Early Detection of Dengue Infection
Condition: Infectious Diseases
Intervention:
92 Completed Study of HBV-001 D1 in Healthy Adults
Condition: Dengue Fever
Interventions: Biological: DEN1-80E (HBV-001 D1 + 3.5 mg Alhydrogel);   Biological: Placebo for DEN1-80E
93 Completed Safety of and Immune Response to a West Nile Virus Vaccine (WN/DEN4-3'delta30) in Healthy Adults
Condition: West Nile Fever Encephalitis
Interventions: Biological: WN/DEN4-3'delta30;   Biological: Placebo
94 Recruiting The Pilot Study of Chikungunya Virus Infections in Southern Taiwan
Condition: Chikungunya Virus
Intervention:
95 Completed Safety of and Immune Response to a Tick-Borne Encephalitis Vaccine (LGT(TP21)/DEN4) in Healthy Adults
Condition: Tick-Borne Encephalitis
Interventions: Biological: LGT(TP21)/DEN4;   Biological: Placebo
96 Completed Safety of and Immune Response to a West Nile Virus Vaccine (WN/DEN4delta30) in Healthy Adults
Condition: West Nile Fever
Interventions: Biological: WN/DEN4delta30 vaccine;   Biological: Placebo
97 Completed Specificity Study of Diagnostic for Early Detection of Dengue Infection
Condition: Infectious Diseases
Intervention:
98 Recruiting Chinese and Western Medicine Treatment of Fever Associated With Bleeding Symptoms
Conditions: Viral Haemorrhagic Fever;   Dengue Fever
Interventions: Drug: Western Medicine;   Drug: TCM  and  Western Medicine
99 Recruiting Study to Determine the Safety, Tolerability and Pharmacokinetics of UV-4B Solution Administered Orally in Healthy Subjects
Condition: Dengue Fever
Interventions: Drug: UV-4B;   Drug: Placebo
100 Completed Impact of SQ vs IM Administration of DENVax on Safety and Immunogenicity
Condition: Healthy
Intervention: Biological: DENVax

First Page    Show previous page of results Previous Page (61-80) Studies Shown (81-100) Next Page (101-104) Show next page of results    Last Page
Indicates status has not been verified in more than two years